KINDERHOOK, N.Y.--(BUSINESS WIRE)--American Bio Medica Corporation (NASDAQ:ABMC) has received notice from the NASDAQ Stock Market (“NASDAQ”) that NASDAQ has determined to continue the temporary extension of the bid price and market value of publicly held shares requirements, for approximately two additional weeks, or until July 31, 2009. Based on discussions with the Securities and Exchange Commission, NASDAQ does not expect any further extensions of the suspension. Based on this notice, upon reinstatement of the rules on August 3, 2009, ABMC will have until August 24, 2009 to regain compliance. ABMC can regain compliance, either during the suspension or during the compliance period resuming after the suspension, by achieving a $1.00 closing bid price for a minimum of 10 consecutive trading days.
